Private raises · SEC Form D
CNS Pharmaceuticals, Inc.: $23 million Raised, SEC Form D Filings
Company · Pharmaceuticals · TX · SEC CIK 1729427 · Company page
Form D notices
A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.
| Filed | Type | Offering | Sold | Industry | |
|---|---|---|---|---|---|
| 19 May 2026 | New notice | $23 million | $23 million | Pharmaceuticals | Form D |
Questions and answers
- How much has CNS Pharmaceuticals, Inc. raised?
- CNS Pharmaceuticals, Inc. reported $23 million sold in its largest Form D notice on file; its latest notice was filed on 19 May 2026. Form D amounts are what the issuer reported to the SEC.
- What is CNS Pharmaceuticals, Inc.?
- CNS Pharmaceuticals, Inc. is a company in pharmaceuticals, based in Houston, Texas, according to its SEC Form D filings.
- How many Form D notices has CNS Pharmaceuticals, Inc. filed?
- 1 notice between 19 May 2026 and 19 May 2026 in Tamarly's record, which starts on 1 October 2025.
Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "CNS Pharmaceuticals, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/1729427, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.